Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA07.047c, Pain Management of Peripheral Nerves by Injection
Notification: 04/05/2017 | Effective: 05/05/2017 | Posted: 04/05/2017
Type of policy change: Coverage and/or Reimbursement Position

MA07.029b, Refractive Lenses
Notification: 04/05/2017 | Effective: 05/05/2017 | Posted: 04/05/2017
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

MA08.001b, Vedolizumab (Entyvio®)
Notification: 04/05/2017 | Effective: 05/05/2017 | Posted: 04/05/2017
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA00.005j, Experimental/Investigational Services
Notification: 04/19/2017 | Effective: 07/18/2017 | Posted: 04/19/2017
Type of policy change: Coverage and/or Reimbursement Position

MA08.016b, Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents
Notification: 04/26/2017 | Effective: 05/26/2017 | Posted: 04/26/2017
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update


New Policies
The following Medicare Advantage policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross.
MA06.029, Therapeutic Drug Monitoring for Antidepressants, Antipsychotics or Antiepileptics
Notification: 03/08/2017 | Effective: 04/07/2017 | Posted: 04/07/2017
Type of policy change: This is a new policy.

MA08.086, Nusinersen (Spinraza™)
Effective: 04/19/2017 | Posted: 04/19/2017
Type of policy change: This is a new policy.


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA11.067c, Labiaplasty
Effective: 04/07/2017 | Posted: 04/07/2017
Type of policy change: Medical Necessity Criteria

MA05.050a, Eye Prostheses and Scleral Cover Shell
Notification: 03/08/2017 | Effective: 04/07/2017 | Posted: 04/07/2017
Type of policy change: Medical Necessity Criteria

MA11.036c, Surgical Treatment of Nails
Notification: 03/22/2017 | Effective: 04/21/2017 | Posted: 04/21/2017
Type of policy change: Medical Coding


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA07.003b, Photodynamic Therapy Using Verteporfin (Visudyne®)
Reissue Effective: 04/12/2017 | Reissue Posted: 04/13/2017

MA08.074, Deoxycholic Acid (Kybella™)
Reissue Effective: 04/26/2017 | Reissue Posted: 04/26/2017


Coding Update
The following Medicare Advantage policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
MA08.042d, Ustekinumab (Stelara™) for Subcutaneous Injection
Effective: 04/01/2017 | Posted: 04/04/2017










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.